News
The FDA’s recent heart pump approval gives heart-failure patients a “bridge” therapy until a suitable donor becomes available. The US FDA has approved the HeartWare Ventricular Assist System, to support heart function and…
As only one of three lead sponsors, GSK is to support 60 years of British innovation at the Queen’s Coronation Festival in July 2013. GlaxoSmithKline is to be a headline partner at the Coronation Festival from the 11th to 14th July 2013 to celebrate…
Cystic Fibrosis Foundation Therapeutics and Pfizer have agreed a significant expansion of their research collaboration. The non-profit drug discovery and development affiliate of the Cystic Fibrosis Foundation has announced a major expansion of…
GSK’s promacta has been approved for an additional use of treating hepatitis C patients with a low platelet count. The US FDA has approved GlaxoSmithKline’s promacta for the additional use of treating hepatitis C patients with…
Novartis’ meningitis B vaccine is recommended for approval by the EMA’s Committee for Medicinal Products for Human Use. The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended Novartis’ meningitis…
Roche’s Avastin has been granted a positive opinion from the EMA as a second-line treatment for patients with advanced colorectal cancer. The European Medicines Agency has granted a positive opinion for the additional data of Roche’s Avastin treatment beyond…
Following the launch of TransCelerate earlier this year, Janssen has teamed up with Merck and Lilly to establish a global pharma database to improve the clinical trials process. J&J’s Janssen, has announced its plans to collaborate with Merck and Lilly to establish a global cross-pharmaceutical…
The European Commission has approved AZ and BMS’ diabetes medication, following its rejection by US regulators at the beginning of the year. AstraZeneca and Bristol-Myers Squibb have announced that the European Commission has approved forxiga tablets for…
GSK’s influenza vaccine has been recommended by the FDA’s advisory committee for approval – the FDA is yet to make its final decision. The FDA advisory committee has voted in favour of GlaxoSmithKline’s H5N1 influenza vaccine candidate and…
